
Changhwa J. Cheu
Examiner (ID: 6970)
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1677, 1641 |
| Total Applications | 1728 |
| Issued Applications | 1108 |
| Pending Applications | 178 |
| Abandoned Applications | 490 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15247051
[patent_doc_number] => 10509043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Methods for identification of pregnancy failure
[patent_app_type] => utility
[patent_app_number] => 15/951187
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5488
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15951187
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/951187 | Methods for identification of pregnancy failure | Apr 11, 2018 | Issued |
Array
(
[id] => 14248603
[patent_doc_number] => 10274498
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-04-30
[patent_title] => Analyte detection
[patent_app_type] => utility
[patent_app_number] => 15/946434
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11023
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946434 | Analyte detection | Apr 4, 2018 | Issued |
Array
(
[id] => 14201393
[patent_doc_number] => 10267805
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-04-23
[patent_title] => Analyte detection
[patent_app_type] => utility
[patent_app_number] => 15/946536
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11015
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946536
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946536 | Analyte detection | Apr 4, 2018 | Issued |
Array
(
[id] => 14487805
[patent_doc_number] => 10330684
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-06-25
[patent_title] => Analyte detection
[patent_app_type] => utility
[patent_app_number] => 15/946498
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11023
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946498
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946498 | Analyte detection | Apr 4, 2018 | Issued |
Array
(
[id] => 13524607
[patent_doc_number] => 20180313846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => BLOOD TEST TO PREDICT ENDURANCE ATHLETIC PERFORMANCE
[patent_app_type] => utility
[patent_app_number] => 15/944585
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944585
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944585 | BLOOD TEST TO PREDICT ENDURANCE ATHLETIC PERFORMANCE | Apr 2, 2018 | Abandoned |
Array
(
[id] => 17681863
[patent_doc_number] => 11366111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
[patent_app_type] => utility
[patent_app_number] => 16/497530
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7695
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497530
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497530 | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | Mar 27, 2018 | Issued |
Array
(
[id] => 15438361
[patent_doc_number] => 20200033364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => METHOD FOR SIMULTANEOUS QUANTIFICATION OF ALXN1210 AND ECULIZUMAB IN HUMAN SERUM OR URINE
[patent_app_type] => utility
[patent_app_number] => 16/497999
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497999 | Method for simultaneous quantification of ALXN1210 and eculizumab in human serum or urine | Mar 27, 2018 | Issued |
Array
(
[id] => 14019433
[patent_doc_number] => 20190071710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => METHOD FOR TESTING AND SCREENING P38 MAP KINASE MODIFIERS
[patent_app_type] => utility
[patent_app_number] => 15/936027
[patent_app_country] => US
[patent_app_date] => 2018-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15936027
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/936027 | Method for testing and screening p38 map kinase modifiers | Mar 25, 2018 | Issued |
Array
(
[id] => 15834783
[patent_doc_number] => 20200132673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/496933
[patent_app_country] => US
[patent_app_date] => 2018-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496933 | PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED THEREFROM | Mar 23, 2018 | Abandoned |
Array
(
[id] => 13142325
[patent_doc_number] => 10088489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Compositions and methods for detecting and/or treating inflammation
[patent_app_type] => utility
[patent_app_number] => 15/928625
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 37
[patent_no_of_words] => 26558
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15928625
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/928625 | Compositions and methods for detecting and/or treating inflammation | Mar 21, 2018 | Issued |
Array
(
[id] => 13447197
[patent_doc_number] => 20180275141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG FUNCTION
[patent_app_type] => utility
[patent_app_number] => 15/927575
[patent_app_country] => US
[patent_app_date] => 2018-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15927575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/927575 | Compositions and methods for treatment of lung function | Mar 20, 2018 | Issued |
Array
(
[id] => 13554789
[patent_doc_number] => 20180328942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => METHOD FOR THE DETECTION OF A BINDING PARTNER OF A MULTISPECIFIC BINDER
[patent_app_type] => utility
[patent_app_number] => 15/923773
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923773
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/923773 | Method for the detection of a binding partner of a multispecific binder | Mar 15, 2018 | Issued |
Array
(
[id] => 15711163
[patent_doc_number] => 20200102347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => COMPOSITIONS, METHODS, AND SYSTEMS FOR AFFINITY-BASED PROTEIN INDENTIFICATION AND PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/492038
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492038 | Compositions, methods, and systems for affinity-based protein identification and purification | Mar 6, 2018 | Issued |
Array
(
[id] => 15311611
[patent_doc_number] => 10520505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-31
[patent_title] => Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
[patent_app_type] => utility
[patent_app_number] => 15/910610
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10296
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910610 | Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies | Mar 1, 2018 | Issued |
Array
(
[id] => 15559893
[patent_doc_number] => 20200064358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHOD FOR PROGNOSIS OF THE OUTCOME OF PATIENTS WITH HEART FAILURE (HF)
[patent_app_type] => utility
[patent_app_number] => 16/488067
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488067 | METHOD FOR PROGNOSIS OF THE OUTCOME OF PATIENTS WITH HEART FAILURE (HF) | Feb 27, 2018 | Abandoned |
Array
(
[id] => 12889282
[patent_doc_number] => 20180188269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => DIAGNOSTIC METHODS FOR LIVER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/907369
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15907369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/907369 | DIAGNOSTIC METHODS FOR LIVER DISORDERS | Feb 27, 2018 | Abandoned |
Array
(
[id] => 13300773
[patent_doc_number] => 20180201923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => NUCLEIC ACID-TAGGED COMPOSITIONS AND METHODS FOR MULTIPLEXED PROTEIN-PROTEIN INTERACTION PROFILING
[patent_app_type] => utility
[patent_app_number] => 15/904905
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904905
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904905 | Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling | Feb 25, 2018 | Issued |
Array
(
[id] => 12866326
[patent_doc_number] => 20180180617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => INTERGRIN ALPHA V BETA 6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 15/903047
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903047
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/903047 | INTERGRIN ALPHA V BETA 6 FOR DIAGNOSIS/PROGNOSIS OF COLORECTAL CARCINOMA | Feb 22, 2018 | Abandoned |
Array
(
[id] => 15559881
[patent_doc_number] => 20200064352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Specific GNAI:GIV Interaction Screening Assays, Methods and Compositions
[patent_app_type] => utility
[patent_app_number] => 16/487462
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487462 | Specific GNAI:GIV interaction screening assays, methods and compositions | Feb 21, 2018 | Issued |
Array
(
[id] => 15270175
[patent_doc_number] => 20190383822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => A NEW BIOMARKER FOR PREECLAMPSIA
[patent_app_type] => utility
[patent_app_number] => 16/487179
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487179
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487179 | A NEW BIOMARKER FOR PREECLAMPSIA | Feb 20, 2018 | Abandoned |